Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | -$37 | -$34 | -$34 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $5 | $0 | $14 |
| Change in WC | -$2 | $1 | -$2 | -$9 |
| Other Non-Cash | -$1 | -$1 | $5 | -$3 |
| Operating Cash Flow | -$40 | -$33 | -$31 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$101 | -$123 | -$58 |
| Inv. Sales/Matur. | $56 | $116 | $208 | $55 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $41 | $15 | $86 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$11 | -$14 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $0 |
| Financing Cash Flow | -$11 | -$14 | -$0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10 | -$32 | $55 | -$34 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88 | $119 | $65 | $98 |
| End Cash | $77 | $88 | $119 | $65 |
| Free Cash Flow | -$40 | -$33 | -$31 | -$30 |